Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou 563000, China.
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Oct 15;1209:123433. doi: 10.1016/j.jchromb.2022.123433. Epub 2022 Aug 23.
A reliable method using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) was established to conduct a comprehensive analysis of the chemical constituents of Du-zhi pill (DZP) as well as their metabolites in rat plasma, urine and feces after gastric perfusion. The efficient on-line mass data acquisition modes combined the various off-line mass data mining strategy was applied. A full mass scan was performed, and then accurate MS/MS datasets were obtained through the use of a multiple mass defect filter (MMDF) and dynamic background subtraction (DBS)-dependent data acquisition method. Furthermore, post-acquisition data processing was conducted using various data-mining tools, including extracted ion chromatography (XIC), mass defect filtering (MDF), product ion filtering (PIF), and neutral loss filtering (NLF) (MetabolitePilot™). Finaly, a total of 176 compounds were identified or tentatively characterized in DZP. Moreover, a total of 233 components in vivo, which includes 92 prototype components and 141 metabolites, were unambiguously or tentatively identified in rat plasma, urine and feces. The metabolic pathways, including phase I reactions (hydroxylation, dehydroxylation and hydrogenation) and phase II reactions (acetylation, sulfation, glucuronidation and methylation), for the absorbed constituents, were explored and summarized. This is the first systematic study on the components of DZP and their metabolites in vivo. This study provide a valid analytical strategy for the characterization of chemical compounds and metabolites of TCM formulas. Moreover, an integrative strategy was proposed for the characterization and identification of chemical constituents and metabolites for additional TCM prescriptions.
建立了一种可靠的方法,使用超高效液相色谱与四极杆飞行时间质谱联用(UPLC-Q-TOF-MS),对灌胃后大鼠血浆、尿液和粪便中的逐瘀丸(DZP)的化学成分及其代谢物进行综合分析。采用了高效在线质谱数据采集模式,结合各种离线质谱数据挖掘策略。进行了全质量扫描,然后通过使用多质量缺陷滤波器(MMDF)和动态背景扣除(DBS)相关的数据采集方法,获得准确的 MS/MS 数据集。此外,通过各种数据挖掘工具进行了采集后数据处理,包括提取离子色谱(XIC)、质量缺陷过滤(MDF)、产物离子过滤(PIF)和中性丢失过滤(NLF)(MetabolitePilot™)。最终,在 DZP 中鉴定或暂定鉴定了 176 种化合物。此外,在大鼠血浆、尿液和粪便中,共鉴定出 233 种体内成分,包括 92 种原型成分和 141 种代谢物。探索并总结了吸收成分的代谢途径,包括 I 相反应(羟化、去羟化和加氢)和 II 相反应(乙酰化、硫酸化、葡萄糖醛酸化和甲基化)。这是首次对 DZP 的成分及其体内代谢物进行系统研究。本研究为中药配方的化合物和代谢物的表征提供了有效的分析策略。此外,还提出了一种综合策略,用于表征和鉴定其他中药方剂的化学成分和代谢物。